Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy

JOURNAL ARTICLE published October 2018 in Seminars in Cancer Biology

Authors: Lais Osmani | Frederic Askin | Edward Gabrielson | Qing Kay Li